For anyone who missed it. Particularly, note the part about the Obama administration's strong support for personalized medicine (and Google for more; it is true.) This is good news for DNAG and other companies that own valuable intellectual property, in the personalized medicine space.
Excerpt: "Personalized medicine uses everything from height and weight to gene and gene-expression information to treat patients. Celera and Abbott are trying to develop molecular diagnostic products to aid in the process. The two firms recently updated their deal, which should lower Celera’s operating expenses and give the company room to launch products outside the joint venture with Abbott. So even if a merger never happens, Celera might stand on its own as a solid investment."
Excerpt: "... personalized medicine requires a lot of diagnostic tests... and that is what Celera is working on with Abbott Labs... disease detection, assessing an individuals pre-disposition to certain diseases... monitoring the progression of a disease… and choosing the right therapy…. remember President Obama loves this stuff... because it saves money on health care costs down the line..."
News 
Market Data 
Discover 
AI
